Cargando…
Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists
[Image: see text] The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from bioisosteric replacement of the...
Autores principales: | Valentini, Alice, Schultz-Knudsen, Katrine, Højgaard Hansen, Anders, Tsakoumagkou, Argyro, Jenkins, Laura, Christensen, Henriette B., Manandhar, Asmita, Milligan, Graeme, Ulven, Trond, Rexen Ulven, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547238/ https://www.ncbi.nlm.nih.gov/pubmed/37129317 http://dx.doi.org/10.1021/acs.jmedchem.2c01935 |
Ejemplares similares
-
Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands
por: Sergeev, Eugenia, et al.
Publicado: (2016) -
Chemogenetics defines a short-chain fatty acid receptor gut–brain axis
por: Barki, Natasja, et al.
Publicado: (2022) -
Structure–Activity Relationship Studies of
Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators
por: Ulven, Elisabeth Rexen, et al.
Publicado: (2020) -
Development
and Characterization of Potent Succinate
Receptor Fluorescent Tracers
por: Ciba, Marija, et al.
Publicado: (2023) -
A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias
por: Sergeev, Eugenia, et al.
Publicado: (2017)